Your browser doesn't support javascript.
loading
Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma.
Chen, Robert; Palmer, Joycelynne M; Martin, Peter; Tsai, Nicole; Kim, Young; Chen, Bihong T; Popplewell, Leslie; Siddiqi, Tanya; Thomas, Sandra H; Mott, Michelle; Sahebi, Firoozeh; Armenian, Saro; Leonard, John; Nademanee, Auayporn; Forman, Stephen J.
Afiliação
  • Chen R; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California. Electronic address: rwc755@gmail.com.
  • Palmer JM; Department of Information Sciences, Division of Biostatistics, City of Hope, Duarte, California.
  • Martin P; Department of Hematology/Oncology, Weill Cornell Medical College, New York, New York.
  • Tsai N; Department of Information Sciences, Division of Biostatistics, City of Hope, Duarte, California.
  • Kim Y; Department Pathology, City of Hope, Duarte, California.
  • Chen BT; Department Diagnostic Radiology, City of Hope, Duarte, California.
  • Popplewell L; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Siddiqi T; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Thomas SH; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Mott M; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Sahebi F; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, and Kaiser Permanente, Los Angeles, California.
  • Armenian S; Department of Population Sciences, City of Hope, Duarte, California.
  • Leonard J; Department of Hematology/Oncology, Weill Cornell Medical College, New York, New York.
  • Nademanee A; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Forman SJ; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
Biol Blood Marrow Transplant ; 21(12): 2136-2140, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26211987
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Imunoconjugados / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Imunoconjugados / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article